Skip Navigation



Human Molecular Genetics Advance Access published online on June 22, 2007

Human Molecular Genetics, doi:10.1093/hmg/ddm155
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
16/17/2072    most recent
ddm155v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Piróg-Garcia, K. A.
Right arrow Articles by Briggs, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piróg-Garcia, K. A.
Right arrow Articles by Briggs, M. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP

Katarzyna A. Piróg-Garcia1, Roger S. Meadows1, Lynette Knowles1, Dick Heinegård2, David J. Thornton1, Karl E. Kadler1, Raymond P. Boot-Handford1 and Michael D. Briggs1,*

1 Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, The University of Manchester, Michael Smith Building, Oxford Road, M13 9PT, Manchester, UK 2 Biomedical Centre, Lund University, BMC C12, 221 84, Lund, Sweden

* Correspondence should be addressed to:- Dr Mike Briggs Wellcome Trust Centre for Cell Matrix Research, Faculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK. +44 161 275 5642 (Tel), +44 161 275 5082 (Fax), mike.briggs{at}manchester.ac.uk

Received May 14, 2007; Revised June 16, 2007; Accepted June 16, 2007

Pseudoachondroplasia (PSACH) is one of the more common skeletal dysplasias and results from mutations in cartilage oligomeric matrix protein (COMP). Most COMP mutations identified to date cluster in the TSP3 repeat region of COMP and the mutant protein is retained in the rER of chondrocytes and may result in increased cell death. In contrast, the pathomolecular mechanism of PSACH resulting from C-terminal domain COMP mutations remains largely unknown.

This study describes the generation and analysis of a murine model of mild PSACH resulting from a p.Thr583Met mutation in the CTD of COMP. Mutant animals are normal at birth, but grow slower than their wild type littermates and by 9 weeks of age they have mild short-limb dwarfism. Furthermore, by 16 months of age mutant animals exhibit severe degeneration of articular cartilage, which is consistent with early onset osteoarthritis seen in PSACH patients.

In the growth plates of mutant mice the chondrocyte columns are sparser and poorly organised. Mutant COMP is secreted into the extracellular matrix, but its localisation is disrupted along with the distribution of several COMP binding proteins. Although mutant COMP is not retained within the rER there is an unfolded protein/cell stress response and chondrocyte proliferation is significantly reduced, whilst apoptosis is both increased and spatially dysregulated.

Overall, these data suggests a mutation in the CTD of COMP exerts a dominant-negative effect on both intra- and extracellular processes. This ultimately affects the morphology and proliferation of growth plate chondrocytes, eventually leading to chondrodysplasia and reduced long bone growth.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
K. L. Posey, A. C. Veerisetty, P. Liu, H. R. Wang, B. J. Poindexter, R. Bick, J. L. Alcorn, and J. T. Hecht
An Inducible Cartilage Oligomeric Matrix Protein Mouse Model Recapitulates Human Pseudoachondroplasia Phenotype
Am. J. Pathol., October 1, 2009; 175(4): 1555 - 1563.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. Tan, M. Duquette, A. Joachimiak, and J. Lawler
The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding
FASEB J, August 1, 2009; 23(8): 2490 - 2501.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
J. L. Alcorn, T. M. Merritt, M. C. Farach-Carson, H. H. Wang, and J. T. Hecht
Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein
RNA, April 1, 2009; 15(4): 686 - 695.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
G. Yang, Q. Sun, Y. Teng, F. Li, T. Weng, and X. Yang
PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1{alpha} signaling and endoplasmic reticulum stress
Development, November 1, 2008; 135(21): 3587 - 3597.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. B. Carlson, K. A. Gunderson, and D. F. Mosher
Mutations Targeting Intermodular Interfaces or Calcium Binding Destabilize the Thrombospondin-2 Signature Domain
J. Biol. Chem., October 3, 2008; 283(40): 27089 - 27099.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.